<?xml version="1.0" encoding="utf8"?>
 <!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd"> <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">IJBT</journal-id>
      <journal-title-group>
        <journal-title>International Journal of Blood Transfusion</journal-title>
      </journal-title-group>
      <issn pub-type="epub">3070-1937</issn>
      <publisher>
        <publisher-name>Open Access Pub</publisher-name>
        <publisher-loc>United States</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.14302/issn.3070-1937.ijbt-23-4714</article-id>
      <article-id pub-id-type="publisher-id">IJBT-23-4714</article-id>
      <article-categories>
        <subj-group>
          <subject>research-article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Duffy Red Cell Antigen Phenotype among Indigenous Pregnant Women attending Antenatal Clinic at Federal Teaching Hospital Gombe, Gombe State, North Eastern Nigeria</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ahmed</surname>
            <given-names>M. Gaji</given-names>
          </name>
          <xref ref-type="aff" rid="idm1842161796">1</xref>
          <xref ref-type="aff" rid="idm1842289828">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ann</surname>
            <given-names>Ogbenna</given-names>
          </name>
          <xref ref-type="aff" rid="idm1842277380">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ahmed</surname>
            <given-names>I. Girei</given-names>
          </name>
          <xref ref-type="aff" rid="idm1842280188">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kasim</surname>
            <given-names>M. Pindiga</given-names>
          </name>
          <xref ref-type="aff" rid="idm1842263012">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sani</surname>
            <given-names>Adamu</given-names>
          </name>
          <xref ref-type="aff" rid="idm1842290476">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Saleh</surname>
            <given-names>Yuguda</given-names>
          </name>
          <xref ref-type="aff" rid="idm1842263012">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ademola</surname>
            <given-names>Adewoyin</given-names>
          </name>
          <xref ref-type="aff" rid="idm1842277380">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Davies</surname>
            <given-names>Nosimot Omotola</given-names>
          </name>
          <xref ref-type="aff" rid="idm1842277380">2</xref>
        </contrib>
      </contrib-group>
      <aff id="idm1842161796">
        <label>1</label>
        <addr-line>Department of Haematology and Blood Transfusion, College of Medicine, University of Lagos.</addr-line>
      </aff>
      <aff id="idm1842277380">
        <label>2</label>
        <addr-line>Department of Haematology and Blood Transfusion, College of Medicine, University of Lagos, Lagos State, Nigeria.</addr-line>
      </aff>
      <aff id="idm1842280188">
        <label>3</label>
        <addr-line>Department of Haematology and Blood Transfusion Federal Teaching Hospital Gombe, Gombe State, Nigeria.</addr-line>
      </aff>
      <aff id="idm1842263012">
        <label>4</label>
        <addr-line>Department of Haematology and Blood Transfusion, Federal Teaching Hospital Gombe, Gombe State, Nigeria.</addr-line>
      </aff>
      <aff id="idm1842290476">
        <label>5</label>
        <addr-line>Department of Chemical Pathology, Federal Teaching Hospital Gombe, Gombe State, Nigeria.</addr-line>
      </aff>
      <aff id="idm1842289828">
        <label>*</label>
        <addr-line>Corresponding author</addr-line>
      </aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Anubha</surname>
            <given-names>Bajaj</given-names>
          </name>
          <xref ref-type="aff" rid="idm1842017892">1</xref>
        </contrib>
      </contrib-group>
      <aff id="idm1842017892">
        <label>1</label>
        <addr-line>MD. (Pathology) Panjab University, Department of Histopathology, A.B. Diagnostics, A-1, Ring Road, Rajouri Garden, New Delhi, 110027, India.</addr-line>
      </aff>
      <author-notes>
        <corresp>
  Ahmed M. Gaji, <addr-line>Department of </addr-line><addr-line>Haematology</addr-line><addr-line> and Blood Transfusion, College of Medicine, University of Lagos</addr-line>, <email>mohammedgaji2@gmail.com</email></corresp>
        <fn fn-type="conflict" id="idm1841487476">
          <p>The authors have declared that no competing interests exist.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub" iso-8601-date="2023-12-27">
        <day>27</day>
        <month>12</month>
        <year>2023</year>
      </pub-date>
      <volume>1</volume>
      <issue>1</issue>
      <fpage>9</fpage>
      <lpage>17</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>08</month>
          <year>2023</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>10</month>
          <year>2023</year>
        </date>
        <date date-type="online">
          <day>27</day>
          <month>12</month>
          <year>2023</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>©</copyright-statement>
        <copyright-year>2023</copyright-year>
        <copyright-holder>Ahmed M. Gaji, et al.</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://openaccesspub.org/ijbt/article/2055">This article is available from http://openaccesspub.org/ijbt/article/2055</self-uri>
      <abstract>
        <sec id="idm1842005220">
          <title>Background and Objectives</title>
          <p>Duffy (FY) blood group system is implicated in    transfusion incompatibilities and haemolytic disease of the foetus and newborn (HDFN). The primary objective was to determine the Duffy phenotype among   indigenous pregnant women in Gombe, Gombe State, Nigeria. </p>
        </sec>
        <sec id="idm1842003996">
          <title>Materials and Methods</title>
          <p>This was a Cross sectional study where simple random sampling was employed on consented participants. Two hundred and fifty nine pregnant women attending antenatal clinic at Federal Teaching Hospital Gombe were randomly recruited into the study. About 3mls of blood was taken, and Duffy antigen typed by standard tube technique (LORNE LABORATORY UK).</p>
        </sec>
        <sec id="idm1842005076">
          <title>Results</title>
          <p>Among the Indigenous tribe, the percentage of Fy(a+b+) was seen in 2.2% of  Fulani and 3.4% of Tangale, Fy(a+b-) phenotype was seen in 4.3% of Tangale, 6.8% of Fulani,9.5%  of Tera, 10.3% of Hausa and 10.5% of Waja.  Fy(a-b+) phenotype was seen in 5.3% of Waja, 7.6% of Fulani,8.7% of Tangale, 9.5% of Tera and 12.5% of Bolawa. Fy(a-b-) phenotype was seen in 2.4% of Tula,6.4% of Bolawa,7.3% of Waja, 7.8% of Tera, 17.8% of Tangale, 11.8% of Hausa and 46.5% of Fulani. About 84.6% of the study population had the null Duffy phenotype.</p>
        </sec>
        <sec id="idm1842002988">
          <title>Conclusion</title>
          <p>The research showed the phenotypic distribution of Duffy blood group among the study participants with relatively high percentage of null Duffy phenotype hence possible risk of alloimmunisation. </p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Duffy phenotype</kwd>
        <kwd>Haemolytic disease of foetus and newborn</kwd>
        <kwd>plasmodiasis</kwd>
      </kwd-group>
      <counts>
        <fig-count count="0"/>
        <table-count count="7"/>
        <page-count count="9"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="idm1842001980">
      <title>Background of the Study</title>
      <p>The Duffy (Fy) blood group system is important in clinical medicine due to transfusion incompatibilities and haemolytic disease of the foetus and newborn (HDFN).<xref ref-type="bibr" rid="ridm1849848892">1</xref> However, many causes of acute and delayed haemolytc transfusion            reaction and haemolytic disease of the foetus and neonate are underreported due to poor obstetric and neonatal screening of clinically important rare blood group            system.<xref ref-type="bibr" rid="ridm1849853140">2</xref> The Duffy (Fy) antigen is a glycoprotein found on red cell membrane, endothelium, and epithelial cells of alveoli and collecting tubules of the kidneys.<xref ref-type="bibr" rid="ridm1849853140">2</xref> The antigen act as receptor for chemokines and plasmodium vivax.<xref ref-type="bibr" rid="ridm1849853140">2</xref> Globally,  Haemolytic disease of the foetus and newborn affects an estimated 80 in 100,000 patients annually. <xref ref-type="bibr" rid="ridm1849856532">3</xref> It could lead to bilirubin encephalopathy &amp; late anaemia of infancy.<xref ref-type="bibr" rid="ridm1849929964">4</xref>Though more commonly associated with Rhesus and ABO blood group. Severe haemolytic disease of foetus and newborn has been reported with minor blood groups like the Duffy and Kell blood group system.<xref ref-type="bibr" rid="ridm1849929964">4</xref>Approximately 4% of pregnant women with anti-Fya have been reported to have foetus with severe anaemia, some requiring intrauterine transfusion.<xref ref-type="bibr" rid="ridm1849929964">4</xref>Knowing the distribution of blood group antigens in a specific population, helps to determine the risk of alloimmunization, and among women, the risk of haemolytic disease of foetus and newborn. The distribution of Duffy phenotype among pregnant women in Gombe state is not known, hence the need to determine the primary data.</p>
    </sec>
    <sec id="idm1842007884" sec-type="materials">
      <title>Materials and Methods</title>
      <p>The study took place at Federal Teaching Hospital Gombe (F.T.H.G). This was a cross sectional study. Gombe state is located in northeastern part of Nigeria. It lies in the wooded savanna lands of the Gongola River basin. It is mainly inhabited by the Fulani, Bolewa, Tera (Terawa), Tangale, Hausa, Kanuri, Waja (Wajawa), and Tula peoples.<xref ref-type="bibr" rid="ridm1849959340">5</xref> A total of 259 pregnant women attending the antenatal clinic at the Federal Teaching Hospital Gombe, who consented, were recruited. A simple random sampling (balloting) technique was used to recruit indigenous pregnant women. Those who picked “yes” were included, whereas those who picked “no” were excluded. Socio-demographic information such as age, religion; tribe, marital status, educational level, occupation and previous obstetric history were obtained from consented participants. Three 3ml of venous blood was aseptically collected into EDTA sample bottle from each participants and transported to the lab for processing. Samples were analysed in batches for Duffy antigen using standard tube technique (LORNE LABORATORY UK),<xref ref-type="bibr" rid="ridm1849711796">6</xref> ABO, Rhesus blood grouping <xref ref-type="bibr" rid="ridm1849711004">7</xref> and screening for Plasmodium species using thin and thick blood film by WHO MM-SOP-08.<xref ref-type="bibr" rid="ridm1849708268">8</xref> Data was compiled into an excel spread sheet and analysed using IBM SPSS Version 25.<xref ref-type="bibr" rid="ridm1849708916">9</xref> Analyzed variables were presented inform of frequency and percentage. Level of significance was set at p&lt; 0.05. Ethical approval (NHREC/25/10/2013) was obtained from Research and Ethics Committee of F.T.H.G.</p>
    </sec>
    <sec id="idm1842005940" sec-type="results">
      <title>Result</title>
      <p>All the women were married, 96.5% had secondary school education and above. Majority (91.5%) were between the ages of 18 and 35 years, with a mean age of 26.71 + 4.58years.  Two- hundred and forty-eight (95.7%) where rhesus positive and 114(44.1%) were blood group O positive. (<xref ref-type="table" rid="idm1841823492">Table 1</xref>)</p>
      <table-wrap id="idm1841823492">
        <label>Table 1.</label>
        <caption>
          <title> Socio-demographic data of the study population.</title>
        </caption>
        <table rules="all" frame="box">
          <tbody>
            <tr>
              <th>
                <bold>Variable</bold>
              </th>
              <td>
                <bold>Frequency (n=259)</bold>
              </td>
              <td>
                <bold>Percent (%)</bold>
              </td>
            </tr>
            <tr>
              <td>
                <bold>Age group</bold>
              </td>
              <td> </td>
              <td> </td>
            </tr>
            <tr>
              <td>18-25 years</td>
              <td>110</td>
              <td>42.5</td>
            </tr>
            <tr>
              <td>26-35 years</td>
              <td>127</td>
              <td>49.0</td>
            </tr>
            <tr>
              <td>36-45 years</td>
              <td>22</td>
              <td>8.5</td>
            </tr>
            <tr>
              <td>
                <bold>Religion</bold>
              </td>
              <td> </td>
              <td> </td>
            </tr>
            <tr>
              <td>Islam</td>
              <td>193</td>
              <td>74.5</td>
            </tr>
            <tr>
              <td>Christianity</td>
              <td>66</td>
              <td>25.5</td>
            </tr>
            <tr>
              <td>
                <bold>Marital status</bold>
              </td>
              <td> </td>
              <td> </td>
            </tr>
            <tr>
              <td>Married</td>
              <td>259</td>
              <td>100</td>
            </tr>
            <tr>
              <td>Unmarried</td>
              <td>0</td>
              <td>0</td>
            </tr>
            <tr>
              <td>
                <bold>Ethnicity</bold>
              </td>
              <td> </td>
              <td> </td>
            </tr>
            <tr>
              <td>Fulani</td>
              <td>118</td>
              <td>45.6</td>
            </tr>
            <tr>
              <td>Tangale</td>
              <td>46</td>
              <td>17.8</td>
            </tr>
            <tr>
              <td>Hausa</td>
              <td>29</td>
              <td>11.2</td>
            </tr>
            <tr>
              <td>Tera</td>
              <td>21</td>
              <td>8.1</td>
            </tr>
            <tr>
              <td>Waja</td>
              <td>19</td>
              <td>7.3</td>
            </tr>
            <tr>
              <td>Bolewa</td>
              <td>16</td>
              <td>6.2</td>
            </tr>
            <tr>
              <td>Tula</td>
              <td>5</td>
              <td>1.9</td>
            </tr>
            <tr>
              <td>Others</td>
              <td>5</td>
              <td>1.9</td>
            </tr>
            <tr>
              <td>
                <bold>Educational level</bold>
              </td>
              <td> </td>
              <td> </td>
            </tr>
            <tr>
              <td>Tertiary</td>
              <td>152</td>
              <td>58.7</td>
            </tr>
            <tr>
              <td>Secondary</td>
              <td>98</td>
              <td>37.8</td>
            </tr>
            <tr>
              <td>Primary</td>
              <td>6</td>
              <td>2.3</td>
            </tr>
            <tr>
              <td>None</td>
              <td>3</td>
              <td>1.2</td>
            </tr>
            <tr>
              <td>
                <bold>Occupation</bold>
              </td>
              <td> </td>
              <td> </td>
            </tr>
            <tr>
              <td>Full time house wife</td>
              <td>138</td>
              <td>53.3</td>
            </tr>
            <tr>
              <td>Civil servant</td>
              <td>58</td>
              <td>22.8</td>
            </tr>
            <tr>
              <td>Student</td>
              <td>24</td>
              <td>9.3</td>
            </tr>
            <tr>
              <td>Entrepreneur</td>
              <td>23</td>
              <td>8.9</td>
            </tr>
            <tr>
              <td>Applicant</td>
              <td>15</td>
              <td>5.8</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="idm1841903644">
            <label/>
            <p>Note: Mean age of the participants = 26.71 + 4.58years, Median age = 26 years (IQR: 20-30), Others; Yoruba and Igbo, Shuwa.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>The major indigenous tribes in this study were Fulani’s (45.6%), Tangale’s (17.8%), and Hausa’s (11.2%). Tera’s, Waja’s, Bolewa’s and Tula’s make up the rest (23.5%) of the population. Tula’s were only 5 out of 259 (1.9%) participants. (<xref ref-type="table" rid="idm1841688172">Table 2</xref>)</p>
      <table-wrap id="idm1841688172">
        <label>Table 2.</label>
        <caption>
          <title> Distribution of ABO, Rhesus blood group system and Obstetric History.</title>
        </caption>
        <table rules="all" frame="box">
          <tbody>
            <tr>
              <th>
                <bold>Variable</bold>
              </th>
              <td>
                <bold>Frequency (=259)</bold>
              </td>
              <td>
                <bold>Percent (%)</bold>
              </td>
            </tr>
            <tr>
              <td>
                <bold>ABO group</bold>
              </td>
              <td> </td>
              <td> </td>
            </tr>
            <tr>
              <td>A</td>
              <td>78</td>
              <td>30.1</td>
            </tr>
            <tr>
              <td>B</td>
              <td>56</td>
              <td>21.6</td>
            </tr>
            <tr>
              <td>AB</td>
              <td>11</td>
              <td>4.2</td>
            </tr>
            <tr>
              <td>O</td>
              <td>114</td>
              <td>44.1</td>
            </tr>
            <tr>
              <td>
                <bold>Rh group</bold>
              </td>
              <td> </td>
              <td> </td>
            </tr>
            <tr>
              <td>Positive</td>
              <td>248</td>
              <td>95.7</td>
            </tr>
            <tr>
              <td>Negative</td>
              <td>11</td>
              <td>4.3</td>
            </tr>
            <tr>
              <td>
                <bold>Miscarriages</bold>
              </td>
              <td> </td>
              <td> </td>
            </tr>
            <tr>
              <td>Yes</td>
              <td>88</td>
              <td>34</td>
            </tr>
            <tr>
              <td>No</td>
              <td>171</td>
              <td>66</td>
            </tr>
            <tr>
              <td>
                <bold>Still births</bold>
              </td>
              <td> </td>
              <td> </td>
            </tr>
            <tr>
              <td>Yes</td>
              <td>21</td>
              <td>8.1</td>
            </tr>
            <tr>
              <td>No</td>
              <td>238</td>
              <td>91.9</td>
            </tr>
            <tr>
              <td>
                <bold>History of neonatal Jaundice</bold>
              </td>
              <td> </td>
              <td> </td>
            </tr>
            <tr>
              <td>Yes</td>
              <td>61</td>
              <td>23.6</td>
            </tr>
            <tr>
              <td>No</td>
              <td>198</td>
              <td>76.4</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="idm1841884460">
            <label/>
            <p>Note. N=Sample size, Rh=Rhesus blood group</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>The most predominant Duffy phenotype among the study population was Fy(a-b-). This was observed in 84.6% of the women (<xref ref-type="table" rid="idm1841628636">Table3</xref>). The Fy(a-b-) was seen in 82.2% of Fulani’s, 89.7% of Hausa’s and 84.8% of Tangale’s, 81.0% of Tera’s. 84.2% of Waja’s. The least proportion (68.75%) was seen among the Bolewa’s (<xref ref-type="table" rid="idm1841589500">Table 4</xref>). The Fy (a+b+) was the least common phenotype seen in only 1.9% of the study population. It was not seen in the Hausas’, Tera’s and the Waja’s. The highest proportion for the Fy(a+ b+) was seen among the Bolewa’s. (<xref ref-type="table" rid="idm1841589500">Table 4</xref>). Thirty-four percent (34%) had a history of miscarriage, 23.6% had history of neonatal jaundice and 8.1% had a history of still births. However the proportion with this bad obstetric history did not vary across the different Duffy phenotypes (<xref ref-type="table" rid="idm1841455220">Table 5</xref>). A hundred and thirty-five (51.1%) pregnant women had malaria parasite by microscopy; 65.2% had P. falciparum infestation, 12.6% had P.vivax, 11.2% had P.malariae and P.ovale (<xref ref-type="table" rid="idm1841361044">Table 6</xref>). P falciparum was the predominant malaria specie seen among participant with Fy (a-b-) (74.52%) and Fy(a+b-) phenotypes (60%), while P.vivax was the predominant specie among those with the Fy(a-b+) (71.43%) and Fy(a+b+) (80%) phenotypes. None of the participants with the null Duffy phenotype has P vivax infestation. (<xref ref-type="table" rid="idm1841307708">Table 7</xref>)</p>
      <table-wrap id="idm1841628636">
        <label>Table3.</label>
        <caption>
          <title> Distribution of Duffy blood group phenotype among participants</title>
        </caption>
        <table rules="all" frame="box">
          <tbody>
            <tr>
              <th>
                <bold> </bold>
              </th>
              <td>
                <bold>Frequency (n=259)</bold>
              </td>
              <td>
                <bold>Percent (%)</bold>
              </td>
            </tr>
            <tr>
              <td>
                <bold>Duffy phenotypes</bold>
              </td>
              <td> </td>
              <td> </td>
            </tr>
            <tr>
              <td>Fy (a+b-)</td>
              <td>17</td>
              <td>6.6</td>
            </tr>
            <tr>
              <td>Fy (a-b+)</td>
              <td>18</td>
              <td>6.9</td>
            </tr>
            <tr>
              <td>Fy (a+b+)</td>
              <td>5</td>
              <td>1.9</td>
            </tr>
            <tr>
              <td>Fy (a-b-)</td>
              <td>219</td>
              <td>84.6</td>
            </tr>
            <tr>
              <td>
                <bold>Total</bold>
              </td>
              <td>259</td>
              <td>100</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="idm1841827396">
            <label/>
            <p>Fy; Duffy antigen, n; sample size.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <table-wrap id="idm1841589500">
        <label>Table 4.</label>
        <caption>
          <title> Distribution of Duffy blood group amongst the ethnic group</title>
        </caption>
        <table rules="all" frame="box">
          <tbody>
            <tr>
              <th>
                <bold>Ethnic groups</bold>
              </th>
              <td>
                <bold>Frequency (n=259)</bold>
              </td>
              <td>
                <bold>Percent (%)</bold>
              </td>
            </tr>
            <tr>
              <th>
                <bold>Fulani</bold>
              </th>
              <td>
                <bold> </bold>
              </td>
              <td>
                <bold> </bold>
              </td>
            </tr>
            <tr>
              <td>Fy (a+b-)</td>
              <td>8</td>
              <td>6.8</td>
            </tr>
            <tr>
              <td>Fy (a-b+)</td>
              <td>9</td>
              <td>7.6</td>
            </tr>
            <tr>
              <td>Fy (a+b+)</td>
              <td>4</td>
              <td>3.4</td>
            </tr>
            <tr>
              <td>Fy (a-b-)</td>
              <td>97</td>
              <td>82.2</td>
            </tr>
            <tr>
              <td>
                <bold>Hausa</bold>
              </td>
              <td> </td>
              <td> </td>
            </tr>
            <tr>
              <td>Fy (a+b-)</td>
              <td>3</td>
              <td>10.3</td>
            </tr>
            <tr>
              <td>Fy (a-b-)</td>
              <td>26</td>
              <td>89.7</td>
            </tr>
            <tr>
              <th>
                <bold>Tangale</bold>
              </th>
              <td>
                <bold> </bold>
              </td>
              <td>
                <bold> </bold>
              </td>
            </tr>
            <tr>
              <td>Fy (a+b-)</td>
              <td>2</td>
              <td>4.3</td>
            </tr>
            <tr>
              <td>Fy (a-b+)</td>
              <td>4</td>
              <td>8.7</td>
            </tr>
            <tr>
              <td>Fy (a+b+)</td>
              <td>1</td>
              <td>2.2</td>
            </tr>
            <tr>
              <td>Fy (a-b-)</td>
              <td>39</td>
              <td>84.8</td>
            </tr>
            <tr>
              <th>
                <bold>Tera</bold>
              </th>
              <td>
                <bold> </bold>
              </td>
              <td>
                <bold> </bold>
              </td>
            </tr>
            <tr>
              <td>Fy (a+b-)</td>
              <td>2</td>
              <td>9.5</td>
            </tr>
            <tr>
              <td>Fy (a-b+)</td>
              <td>2</td>
              <td>9.5</td>
            </tr>
            <tr>
              <td>Fy (a-b-)</td>
              <td>17</td>
              <td>81.0</td>
            </tr>
            <tr>
              <td>
                <bold>Waja</bold>
              </td>
              <td> </td>
              <td> </td>
            </tr>
            <tr>
              <td>Fy (a+b-)</td>
              <td>2</td>
              <td>10.5</td>
            </tr>
            <tr>
              <td>Fy (a-b+)</td>
              <td>1</td>
              <td>5.3</td>
            </tr>
            <tr>
              <td>Fy (a-b-)</td>
              <td>16</td>
              <td>84.2</td>
            </tr>
            <tr>
              <th>
                <bold>Bolewa</bold>
              </th>
              <td>
                <bold> </bold>
              </td>
              <td>
                <bold> </bold>
              </td>
            </tr>
            <tr>
              <td>Fy (a+b-)</td>
              <td>2</td>
              <td>12.5</td>
            </tr>
            <tr>
              <td>Fy (a-b+)</td>
              <td>1</td>
              <td>6.25</td>
            </tr>
            <tr>
              <td>Fy (a+b+)</td>
              <td>2</td>
              <td>12.5</td>
            </tr>
            <tr>
              <td>Fy (a-b-)</td>
              <td>11</td>
              <td>68.75</td>
            </tr>
            <tr>
              <th>
                <bold>Tula</bold>
              </th>
              <td>
                <bold> </bold>
              </td>
              <td>
                <bold> </bold>
              </td>
            </tr>
            <tr>
              <td>Fy (a-b-)</td>
              <td>5</td>
              <td>100</td>
            </tr>
            <tr>
              <td>
                <bold>Others</bold>
              </td>
              <td> </td>
              <td> </td>
            </tr>
            <tr>
              <td>Fy (a-b-)</td>
              <td>5</td>
              <td>100</td>
            </tr>
            <tr>
              <td>Total n (%)</td>
              <td>259</td>
              <td>100</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="idm1841740724">
            <label/>
            <p>Note: Others; Yoruba, Igbo, Shuwa</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <table-wrap id="idm1841455220">
        <label>Table 5.</label>
        <caption>
          <title> Distribution of Duffy phenotype and negative obstetric history</title>
        </caption>
        <table rules="all" frame="box">
          <tbody>
            <tr>
              <td> </td>
              <td>
                <bold>Fy(</bold>
                <bold>a+b</bold>
                <bold>-)</bold>
                <bold>n (%)</bold>
              </td>
              <td>
                <bold>Fy(a-b+)</bold>
                <bold>n (%)</bold>
              </td>
              <td>
                <bold>Fy(</bold>
                <bold>a+b</bold>
                <bold>+)</bold>
                <bold>n (%)</bold>
              </td>
              <td>
                <bold>Fy(a-b-)</bold>
                <bold>n (%)</bold>
              </td>
              <td>
                <bold>Total</bold>
                <bold>n (%)</bold>
              </td>
              <td>
                <bold>P                 value</bold>
              </td>
            </tr>
            <tr>
              <td>
                <bold>Miscarriages</bold>
              </td>
              <td> </td>
              <td> </td>
              <td> </td>
              <td> </td>
              <td> </td>
              <td> </td>
            </tr>
            <tr>
              <td>       Yes</td>
              <td>3(17.65)</td>
              <td>8(44.44)</td>
              <td>0(0.00)</td>
              <td>77(34.16)</td>
              <td>88(33.98)</td>
              <td>0.52</td>
            </tr>
            <tr>
              <td>        No</td>
              <td>14(82.35)</td>
              <td>10(55.56)</td>
              <td>5(100.00)</td>
              <td>142(64.64)</td>
              <td>171(66.02)</td>
              <td> </td>
            </tr>
            <tr>
              <td>
                <bold>Still birth</bold>
              </td>
              <td> </td>
              <td> </td>
              <td> </td>
              <td> </td>
              <td> </td>
              <td> </td>
            </tr>
            <tr>
              <td>        Yes</td>
              <td>0(0.00)</td>
              <td>2(11.11)</td>
              <td>0(0.00)</td>
              <td>19(8.68)</td>
              <td>21(8.11)</td>
              <td>0.07</td>
            </tr>
            <tr>
              <td>         No</td>
              <td>17(100.00)</td>
              <td>16(88.89)</td>
              <td>5(100.00)</td>
              <td>200(91.32)</td>
              <td>238(91.89)</td>
              <td> </td>
            </tr>
            <tr>
              <td>
                <bold>Neonatal jaundice</bold>
              </td>
              <td> </td>
              <td> </td>
              <td> </td>
              <td> </td>
              <td> </td>
              <td> </td>
            </tr>
            <tr>
              <td>        Yes</td>
              <td>8(7.06)</td>
              <td>5 (27.78)</td>
              <td>1(20.00)</td>
              <td>47(21.26)</td>
              <td>61 (23.55)</td>
              <td>0.52</td>
            </tr>
            <tr>
              <td>         No</td>
              <td>         9   (52.94)</td>
              <td>      13   (72.22)</td>
              <td>         4    (80.00)</td>
              <td>       172     (78.54)</td>
              <td>        198     (76.45)</td>
              <td> </td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap id="idm1841361044">
        <label>Table 6.</label>
        <caption>
          <title> Prevalence of malaria parasitaemia among participants and type of plasmodium species.</title>
        </caption>
        <table rules="all" frame="box">
          <tbody>
            <tr>
              <th>
                <bold> </bold>
              </th>
              <td>
                <bold>Frequency</bold>
              </td>
              <td>
                <bold>Percent (%)</bold>
              </td>
            </tr>
            <tr>
              <th>
                <bold>Malaria </bold>
                <bold>parasiteamia</bold>
                <bold> (n=259)</bold>
              </th>
              <td> </td>
              <td> </td>
            </tr>
            <tr>
              <td>Not seen</td>
              <td>124</td>
              <td>47.9</td>
            </tr>
            <tr>
              <td>Seen</td>
              <td>135</td>
              <td>51.1</td>
            </tr>
            <tr>
              <td>
                <bold>Plasmodium species (n=135)</bold>
              </td>
              <td>
                <bold> </bold>
              </td>
              <td> </td>
            </tr>
            <tr>
              <td>
                <italic>P. falciparum</italic>
              </td>
              <td>88</td>
              <td>65.2</td>
            </tr>
            <tr>
              <td>
                <italic>P. vivax</italic>
              </td>
              <td>17</td>
              <td>12.6</td>
            </tr>
            <tr>
              <td>
                <italic>P. malariae</italic>
              </td>
              <td>15</td>
              <td>11.1</td>
            </tr>
            <tr>
              <td>
                <italic>P. </italic>
                <italic>ovale</italic>
              </td>
              <td>15</td>
              <td>11.1</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap id="idm1841307708">
        <label>Table 7.</label>
        <caption>
          <title> Distribution of plasmodium species based on Duffy antigen status of participants.</title>
        </caption>
        <table rules="all" frame="box">
          <tbody>
            <tr>
              <td>
                <bold> </bold>
              </td>
              <td>
                <bold>Fy(</bold>
                <bold>a+b</bold>
                <bold>-)</bold>
                <bold>n (%)</bold>
              </td>
              <td>
                <bold>Fy(a-b+)</bold>
                <bold>n (%)</bold>
              </td>
              <td>
                <bold>Fy(</bold>
                <bold>a+b</bold>
                <bold>+)</bold>
                <bold>n (%)</bold>
              </td>
              <td>
                <bold>Fy(a-b-)</bold>
                <bold>n (%)</bold>
              </td>
              <td>
                <bold>*P value</bold>
              </td>
            </tr>
            <tr>
              <td>P.falciparum</td>
              <td>6 (60.00)</td>
              <td>2 (14.29)</td>
              <td>1 (20.00)</td>
              <td>79 (74.53)</td>
              <td>0.001</td>
            </tr>
            <tr>
              <td>P.malariae</td>
              <td>0 (0.00)</td>
              <td>2 (14.29)</td>
              <td>0 (0.00)</td>
              <td>13 (12.26)</td>
              <td>
                <bold> </bold>
              </td>
            </tr>
            <tr>
              <td>P.vivax</td>
              <td>3 (30.00)</td>
              <td>10 (71.43)</td>
              <td>4 (80.00)</td>
              <td>0 (0.00)</td>
              <td>
                <bold> </bold>
              </td>
            </tr>
            <tr>
              <td>P.ovale</td>
              <td>1 (10.00)</td>
              <td>0 (0.00)</td>
              <td>0 (0.00)</td>
              <td>14 (13.21)</td>
              <td>
                <bold> </bold>
              </td>
            </tr>
            <tr>
              <td>Total</td>
              <td>10 (100.00)</td>
              <td>14 (100.00)</td>
              <td>5 (100.00)</td>
              <td>106 (100.00)</td>
              <td>
                <bold> </bold>
              </td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="idm1841597732">
            <label/>
            <p>*Pearson’s chi square</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec id="idm1841597156" sec-type="discussion">
      <title>Discussion</title>
      <p>The Duffy blood group antibodies are IgG antibodies and have the ability to cross the placental barrier and hence are associated with risk of haemolytic disease of foetus and new born. We investigated the prevalence and distribution of the Duffy blood group antigen among pregnant women in Gombe State, North - East Nigeria.</p>
      <p>In this study, the null phenotype was the most prevalent phenotype seen in 80- 86% of pregnant women from all the major ethnic groups in Gombe, except among the Bolewa, where it accounted for 69% of the pregnant women.  This agrees with previous study among blacks in sub Saharan Africa.<xref ref-type="bibr" rid="ridm1849706540">10</xref>In a related study in Sokoto, a state in North West Nigeria, all the pregnant Fulani’s women (20/162) in the study lacked both the Fya and Fyb antigen, implying they also had a null phenotype. Kulkarni et al.,<xref ref-type="bibr" rid="ridm1849701476">11</xref> Erhabor et al., <xref ref-type="bibr" rid="ridm1849701044">12</xref> also reported 98.8% of Duffy negativity among Hausa’s in North West Nigeria. The prevalence rate of  Fy (a+b-),  Fy (a-b+) and Fy (a+b+) phenotype disagree with the research carried out in north western Nigeria<xref ref-type="bibr" rid="ridm1849701044">12</xref>, where prevalence rate of 4.3%, 5.6% and 0.61% were reported respectively. </p>
      <p>In another research carried out at donor clinic of Aminu Kano teaching hospital, using potent antisera, Duffy antigens were not detected among the blood donors. <xref ref-type="bibr" rid="ridm1849698668">13</xref></p>
      <p>The Duffy antibody is an immune antibody produced in response to previous exposure and has the ability to cause immediate and delayed transfusion reaction and haemolytic disease of the foetus and newborn. In this study, out of 259 participants, 88 (33.98%) had history of miscarriage, 21 (8.11%) still births and 61 (23.55%) had neonatal jaundice. Contrary to expectations, the proportion of pregnant women with bad obstetric history was higher among the pregnant women with null Fy(a-b-) than those with  Fy(a-b+). Table 5. The pregnant women with null Fy (a-b-) phenotype had the highest history of miscarriages, still births, and neonatal jaundice. The antibody against the Fya antigen (anti-Fya) is 20 times more potent than the anti-Fyb and is associated with mild-to-severe HDFN, than the anti-Fyb. The anti-Fyb is rarely associated with mild HDFN.<xref ref-type="bibr" rid="ridm1849696436">14</xref> Moreover, studies have shown that blacks with the F (a-b-) phenotype who develop Duffy antibodies, do not produce anti-Fyb but usually produce anti-Fya and anti Fya3 or Fy5.<xref ref-type="bibr" rid="ridm1849686460">15</xref>This is because the Fy(a–b–) phenotype in blacks is associated with a mutation (a single amino acid substitution at position 46) which impairs the erythroid promoter, GATA-1 binding motif. The mutation prevents the transcription of the FY gene in the RBCs only while the Duffy Fyb antigen is expressed on the other tissues.<xref ref-type="bibr" rid="ridm1849691284">16</xref></p>
      <p>These and the dosage effect observed in the Duffy blood group though not statistically significant, may explain the differences observed in the obstetric history across the various phenotypes. </p>
      <p>The Duffy antigens serve as receptor for diverse group of chemokines and P. vivax. The Duffy antigen receptor plays a vital role as an immune regulator where it served as a chemokine sink during inflammatory processes. In this study, out of 259 participants, 135 had plasmodiasis, out of which 11.1% were infested with P. malariae and P. ovale respectively, 12.6% P. vivax, and 65.2% P. falciparum. The prevalence rates of plasmodiasis among participants with null Duffy phenotype Fy (a-b-) was 0.0% for P. vivax, 12.26 % P. malaria, 74.53 % P. falciparum and 13.21 % P. ovale. These findings supported previous studies which stated that red cells of null Duffy phenotype individuals resist invasion by P. vivax which was due to non-expression of Duffy antigen on the red cell surface, hence the resistivity.<xref ref-type="bibr" rid="ridm1849692940">17</xref>This study did not screen for allo-antibodies among the pregnant women with the null phenotype. Doing this will have provided more data on the risk of alloimmunization among pregnant women with the null phenotype.</p>
    </sec>
    <sec id="idm1841592980" sec-type="conclusions">
      <title>Conclusions</title>
      <p>The prevalence of the null Duffy phenotype is high among pregnant women in Gombe and hence there may be a high risk of alloimmunization and obstetric complications. The least seen phenotype is the F (a+b+) phenotype.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ridm1849848892">
        <label>1.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Mollison</surname>
            <given-names>P L</given-names>
          </name>
          <name>
            <surname>Engelfried</surname>
            <given-names>C P</given-names>
          </name>
          <name>
            <surname>Contreras</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Blood transfusion in clinical medicine, British journal of haematology</article-title>
          <date>
            <year>1997</year>
          </date>
          <volume>2</volume>
          <fpage>324</fpage>
          <lpage>356</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1849853140">
        <label>2.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Rosenfield</surname>
            <given-names>R E</given-names>
          </name>
          <name>
            <surname>Vogel</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Race</surname>
            <given-names>R R</given-names>
          </name>
          <article-title>A new case of ant-Fya in human serum. Revised Journal of Heamatology</article-title>
          <date>
            <year>1950</year>
          </date>
          <volume>5</volume>
          <fpage>315</fpage>
          <lpage>317</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1849856532">
        <label>3.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Delaney</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Matthews</surname>
            <given-names>D C</given-names>
          </name>
          <article-title>Haemolytic disease of the foetus and newborn: managing the mother, foetus and newborn</article-title>
          <source>Journal of American society of Haematology</source>
          <volume>2015</volume>
          <fpage>146</fpage>
          <lpage>51</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1849929964">
        <label>4.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Hughes</surname>
            <given-names>L H</given-names>
          </name>
          <name>
            <surname>Rossi</surname>
            <given-names>K Q</given-names>
          </name>
          <name>
            <surname>Krugh</surname>
            <given-names>D W</given-names>
          </name>
          <name>
            <surname>O’</surname>
            <given-names>Shaughnessy RW</given-names>
          </name>
          <article-title>Management of pregnancies complicated by anti-Fya (a) alloimmunization. Transfusion</article-title>
          <date>
            <year>2007</year>
          </date>
          <volume>47</volume>
          <fpage>1858</fpage>
          <lpage>61</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1849959340">
        <label>5.</label>
        <mixed-citation xlink:type="simple" publication-type="journal"><article-title>National population commission:</article-title><date><year>2006</year></date>
PHC Priority tables.poipulation.gov.ng.2018


</mixed-citation>
      </ref>
      <ref id="ridm1849711796">
        <label>6.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <article-title>Lorne laboratories ltd. Anti-Fya monoclonal, Anti-Fyb polyclonal,email:info@lornelabs.com</article-title>
        </mixed-citation>
      </ref>
      <ref id="ridm1849711004">
        <label>7.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Seraclone</surname>
            <given-names>ABO Blood</given-names>
          </name>
          <article-title>Group and Rh Reagents. Bio-Rad Laboratories.Contactemeacustomerservice@bio-rad.com</article-title>
        </mixed-citation>
      </ref>
      <ref id="ridm1849708268">
        <label>8.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <article-title>WHO. Bench for Malaria diagnosis</article-title>
          <date>
            <year>2009</year>
          </date>
          <source>Geneva</source>
          <fpage>1</fpage>
          <lpage>5</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1849708916">
        <label>9.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>George</surname>
            <given-names>Darren</given-names>
          </name>
          <name>
            <surname>Mallery</surname>
            <given-names>Paul</given-names>
          </name>
          <article-title>step by step: simple guide and reference</article-title>
          <source>IBM SPSS Statistics</source>
          <volume>25</volume>
          <fpage>404</fpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1849706540">
        <label>10.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Le</surname>
            <given-names>Pennec PY</given-names>
          </name>
          <name>
            <surname>Rouger</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Klein</surname>
            <given-names>M T</given-names>
          </name>
          <name>
            <surname>Robert</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Salmon</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Study of anti-Fya in five black Fy(a−b−) patients. Vox Sang</article-title>
          <date>
            <year>1987</year>
          </date>
          <volume>52</volume>
          <fpage>246</fpage>
          <lpage>9</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1849701476">
        <label>11.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Akunwata</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Duffy Antigens and Malaria: The African Experience. Blood Groups - More than Inheritance of Antigenic Substances [Internet]</article-title>
          <date>
            <year>2022</year>
          </date>
        </mixed-citation>
      </ref>
      <ref id="ridm1849701044">
        <label>12.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Erhabor</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Shehu</surname>
            <given-names>C E</given-names>
          </name>
          <name>
            <surname>Alhaji</surname>
            <given-names>Y B</given-names>
          </name>
          <name>
            <surname>Yakubu</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Duffy red cells phenotypes among pregnant women in Sokoto, North Western Nigeria.Journal of Blood disorders and Transfusion</article-title>
          <date>
            <year>2014</year>
          </date>
          <volume>5</volume>
          <fpage>223</fpage>
          <lpage>228</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1849698668">
        <label>13.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Fatima</surname>
            <given-names>A Aldarweesh</given-names>
          </name>
          <article-title>The Duffy blood group system</article-title>
          <source>Journal of Intech Open</source>
          <volume>2019</volume>
          <fpage>1</fpage>
          <lpage>4</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1849696436">
        <label>14.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Vengelen-Tyler</surname>
            <given-names>V</given-names>
          </name>
          <article-title>Anti-Fya preceding anti-Fy3 or -Fy5: a study of five cases (abstract). Transfusion</article-title>
          <date>
            <year>1985</year>
          </date>
          <fpage>25</fpage>
          <lpage>482</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1849686460">
        <label>15.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Le</surname>
            <given-names>Pennec PY</given-names>
          </name>
          <name>
            <surname>Rouger</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Klein</surname>
            <given-names>M T</given-names>
          </name>
          <name>
            <surname>Robert</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Salmon</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Study of anti-Fya in five black Fy(a−b−) patients. Vox Sang 1987;52:</article-title>
          <fpage>246</fpage>
          <lpage>9</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1849691284">
        <label>16.</label>
        <mixed-citation xlink:type="simple" publication-type="journal"><name><surname>Aldarweesh</surname><given-names>F</given-names></name><article-title>The Duffy Blood Group System [Internet]. Human Blood Group Systems and Haemoglobinopathies. IntechOpen;</article-title><date><year>2021</year></date>
Available from: http://dx.doi.org/10.5772/intechopen.89952


</mixed-citation>
      </ref>
      <ref id="ridm1849692940">
        <label>17.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Moise</surname>
            <given-names>K J</given-names>
          </name>
          <article-title>Fetal anaemia due to non-Rhesus-D red cell alloimmunization.Semin fetal neonatal Medicine</article-title>
          <date>
            <year>2008</year>
          </date>
          <volume>13</volume>
          <issue>4</issue>
          <fpage>207</fpage>
          <lpage>14</lpage>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
